Fox Run Management L.L.C. Invests $669,000 in Genpact Limited (NYSE:G)

Fox Run Management L.L.C. bought a new stake in Genpact Limited (NYSE:G) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 15,573 shares of the business services provider’s stock, valued at approximately $669,000.

Several other hedge funds also recently modified their holdings of the stock. Advisors Asset Management Inc. lifted its stake in Genpact by 3.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 6,885 shares of the business services provider’s stock valued at $270,000 after acquiring an additional 226 shares in the last quarter. Cerity Partners LLC raised its holdings in shares of Genpact by 136.4% in the third quarter. Cerity Partners LLC now owns 17,935 shares of the business services provider’s stock valued at $703,000 after purchasing an additional 10,349 shares during the last quarter. Centaurus Financial Inc. bought a new position in shares of Genpact during the third quarter valued at about $159,000. BNP Paribas Financial Markets boosted its holdings in Genpact by 78.8% during the third quarter. BNP Paribas Financial Markets now owns 47,957 shares of the business services provider’s stock worth $1,880,000 after purchasing an additional 21,140 shares during the last quarter. Finally, Glenmede Trust Co. NA grew its position in Genpact by 2.2% in the 3rd quarter. Glenmede Trust Co. NA now owns 43,156 shares of the business services provider’s stock worth $1,692,000 after purchasing an additional 926 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on G. Needham & Company LLC lifted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Mizuho upped their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Finally, Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their target price for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $48.44.

Insider Buying and Selling at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.

Genpact Stock Up 0.1 %

Shares of NYSE G opened at $49.93 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a market capitalization of $8.77 billion, a PE ratio of 17.58, a P/E/G ratio of 1.84 and a beta of 1.16. Genpact Limited has a one year low of $30.23 and a one year high of $56.76. The business’s fifty day moving average price is $50.38 and its 200-day moving average price is $44.78.

Genpact (NYSE:G) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities research analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.36%. This is a positive change from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s payout ratio is currently 23.94%.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.